BridgeMD
New treatment option for Transcranial Direct Current Stimulation
Official title Effects of tDCS for Enhancing Cognitive Function in Individuals With Persistent Post-Concussion Syndrome
ClinicalTrials.gov ID: NCT06376500
What this study is testing
- What it's testing
- Globally, 10 million new traumatic brain injury (TBI) cases are estimated annually, with mild traumatic brain injury (mTBI) accounting for 75-90% of all TBI cases. It is estimated that 40-80% of individuals with mTBI may experience the post-concussion syndrome (PCS), which is characterized by a range of physical, cognitive, and emotional symptoms.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- being 18 years old or older;
- having a history of a mild TBI (less than 30 minutes loss of consciousness) 1-6 years prior to the study;
- able to communicate in Chinese.
You likely can't join if
- being without a confirmed diagnosis from the medical practitioner;
- having a history of other neurological and psychiatric disorders, skull defect, recent medical instability (within 3 weeks);
- being pregnant;
- being medication for a psychiatric condition (e.g., major depression, anxiety, schizophrenia);
- with any implanted devices or suffering from real claustrophobia or feel uncomfortable in small, enclosed spaces, like MRI tunnel
The study team makes the final eligibility decision.
Where it's taking place
- Hung Hom, Kowloon, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hung Hom, Kowloon, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.